Answers are grounded in this paper and cite their sources.
Coagulation tests including platelet count, factor V assay, fibrinogen, fibrin split products, and serial thrombin time were performed on 51 patients with cancer. Elevated fibrin split products and/or abnormal serial thrombin time was present in 24 (48%) patients. Bleeding occurred in three patients; each had normal platelet counts. However, the serial thrombin time was not normal and/or increased fibrin split products were present. The data add support to the hypothesis that cancer patients do have a delicately balanced coagulation mechanism, and chronic disseminated intravascular coagulation may be induced or aggravated by various stimuli, including radiation therapy, chemotherapy, sepsis, and perhaps other unrecognized situations.
No takes yet. Share an insight, caveat, or question.
Peck et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: